Internal Medicine, Gastroenterology · Dothan, AL
NPI
1588981872
Since 2010
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
480 Honeysuckle Rd
Dothan, AL, 36305
Phone (334) 836-1212
Groups this clinician bills Medicare through
Medicare paid, 2024
$444K
20,130 services
Medicare patients, 2024
850
Average age 73
Drug cost, 2024
$3.7M
4,151 prescriptions
Company payments, 2025
$1,550
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott A Sarrels was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 7,200 times for 70 patients. In total Scott A Sarrels billed 20,130 services in 91 codes, and Medicare paid $444K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 7,200 | 70 | $0.10 | $710 |
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 6,000 | 18 | $17.49 | $105K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,838 | 170 | $35.44 | $65K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,091 | 173 | $46.27 | $50K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 950 | 13 | $25.07 | $24K |
| 99214 Office E&M - Established | Office | 404 | 313 | $84.89 | $34K |
| 43239 Upper GI Endoscopy | Facility | 201 | 189 | $50.86 | $10K |
| 99232 Hospital E&M - Subsequent | Facility | 192 | 101 | $56.07 | $11K |
| 45385 Colonoscopy - Lesion Removal | Facility | 163 | 162 | $179.73 | $29K |
| 99204 Office E&M - New | Office | 163 | 163 | $113.52 | $19K |
| 99454 E&M - Miscellaneous | Office | 96 | 15 | $33.17 | $3,185 |
| 99457 E&M - Miscellaneous | Office | 87 | 15 | $36.27 | $3,155 |
| 45380 Lower GI Endoscopy - Other | Facility | 85 | 85 | $50.90 | $4,327 |
| 43249 Upper GI Endoscopy | Facility | 74 | 67 | $98.51 | $7,290 |
| 99222 Hospital E&M - Initial | Facility | 69 | 69 | $97.78 | $6,747 |
By year: 2022 $334K for 16,096 services; 2023 $377K for 18,138 services; 2024 $444K for 20,130 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott A Sarrels prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,286 prescriptions and refills. In total Scott A Sarrels wrote 4,151 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,286 | 2,596 | 376 | $14K |
| Omeprazole Generic | 258 | 562 | 80 | $4,202 |
| Linzess Linaclotide | 195 | 273 | 50 | $146K |
| Famotidine Generic | 159 | 330 | 49 | $2,434 |
| Colesevelam Hcl Generic | 156 | 211 | 51 | $26K |
| Dicyclomine Hcl Generic | 144 | 172 | 46 | $2,632 |
| Ondansetron Hcl Generic | 115 | 115 | 35 | $2,607 |
| Mesalamine Generic | 107 | 172 | 22 | $42K |
| Trulance Plecanatide | 105 | 127 | 27 | $71K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 101 | 101 | 100 | $6,793 |
| Creon Lipase/Protease/Amylase | 93 | 108 | 29 | $250K |
| Ondansetron Odt Ondansetron | 83 | 94 | 43 | $1,555 |
| Lubiprostone Generic | 79 | 94 | 16 | $7,388 |
| Amitriptyline Hcl Generic | 67 | 143 | 19 | $1,277 |
| Motegrity Prucalopride Succinate | 62 | 76 | 11 | $40K |
Brand drugs: - claims; generic drugs: 3,139 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott A Sarrels $1,550 ($1,550 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $392.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $392 |
| Medtronic, Inc. MDT | 5 | $146 |
| Lilly USA, LLC LLY | 2 | $137 |
| Genzyme Corporation SNY | 4 | $133 |
| Pfizer Inc. PFE | 6 | $118 |
| CONMED Corporation CNMD | 3 | $113 |
| Janssen Biotech, Inc. JNJ | 6 | $112 |
| Madrigal Pharmaceuticals MDGL | 2 | $95.06 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $80.59 |
| Ardelyx, Inc. ARDX | 3 | $75.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.